Table 2.
Outcome, follow-up | Conventional treatment | Physical therapy | Univariate analysis | Risk difference |
---|---|---|---|---|
n (%) | n (%) | OR (95% CI) | AR% (95% CI) | |
Re-sprain, 3 months | 14 (27) | 10 (23) | 0.80 (0.31 to 2.03) | −4.2 (−21.5 to 13.1%) |
Re-sprain, 12 months | 16 (31) | 13 (29) | 0.91 (0.38 to 2.19) | 2.5 (−16.8 to 22.0%) |
Reported instability, 3 months | 34 (64) | 32 (65) | 1.05 (0.47 to 2.37) | 1.2 (−17.4 to 19.7%) |
Reported instability, 12 months | 30 (57) | 26 (53) | 0.87 (0.40 to 1.89) | 3.5 (−22.9 to 15.8%) |
Tested instability, 3 months | 26 (57) | 18 (45) | 0.63 (0.27 to 1.48) | −11.5 (−32.6 to 9.5%) |
Full treatment appreciation, 3 months | 32 (68) | 40 (91) | 4.69 (1.41 to15.5)b | 22.8 (7.0 to 38.7%) |
Mean (SD) | Mean (SD) | Mean difference (95% CI) | Effect size (95% CI) | |
Subjective recovery, 3 months | 7.8 (2.4) | 8.2 (2.4) | 0.33 (−0.60 to 1.27) | 0.14 (−0.25 to 0.54) |
Subjective recovery, 12 months | 8.6 (1.9) | 8.3 (2.8) | −0.28 (−1.22 to 0.66) | −0.12 (−0.51 to 0.28) |
ROM difference, 3 monthsc | 3.7 (8.0) | 1.9 (6.1) | −1.82 (−4.96 to 1.32) | −0.25 (−0.69 to 0.18) |
Primary outcomes in bold.
P≤0.05.
Injured ankle versus non-injured ankle. ROM = range of movement. AR = attributive risk.